Percutaneous Vertebroplasty of the Entire Thoracic and Lumbar Vertebrae for Vertebral Compression Fractures Related to Chronic Glucocorticosteriod Use: Case Report and Review of Literature

Tian, Qinghua; Wu, Chun; Quanping, Xiao; He, Cheng-Jian; Gu, Yu; Wang, Tao; Li, Minghua

doi:10.3348/kjr.2014.15.6.797

Cited by 6 publications

(8 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PVP and PKP may have less beneficial effects in glucocorticoid-induced osteoporosis (GIOP) than in primary osteoporosis as studies have shown that PVP and PKP might predispose patients to re-fracture through the shifting of the normal load transmission through the spine [28,29]. Tian et al [30] reviewed the literature regarding PVP or PKP in GC-related osteoporotic VCF from 1995 to 2013. One hundred and seventeen GIOP patients with VCF from 11 studies were included [30].…”

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

“…Tian et al [30] reviewed the literature regarding PVP or PKP in GC-related osteoporotic VCF from 1995 to 2013. One hundred and seventeen GIOP patients with VCF from 11 studies were included [30]. It was perceived that PVP was a safe and effective procedure for pain relief in selected patients with repeated and/or multiple thoracic-lumbar VCFs related to GCs.…”

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

“…Almost all the re-fractures occurred within a year after PKP or PVP. In order to minimize re-fracture, Tian et al [30] suggested the principle of applying PVP or PKP to not more than three levels of vertebra or not more than 8 mL of bone cement at a time in order to minimize complications resulting from cement, air, and fat emboli. As a consequence of more serious degree of osteoporosis in GIOP patients, smaller amount of thrust during placement of puncture needle into the target vertebra is required [30].…”

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

See 2 more Smart Citations

Update on Symptomatic Treatment of Acute Vertebral Compression Fracture

Wong

Mok

2019

Journal of Clinical Rheumatology and Immunology

View full text Add to dashboard Cite

The vertebral column is the most common site of osteoporotic fracture in older individuals and in those using long-term glucocorticoids. Vertebral compression fracture leads to significant morbidities such as acute and chronic pain, spinal deformities and neurological complications, resulting in reduced mobility and quality of life. As a previous vertebral compression fracture is a strong risk factor for further fragility fractures and mortality, it should be treated appropriately. This article reviews the management of osteoporotic vertebral compression fracture and provides evidence-based treatment options.

show abstract

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

Section: Surgical Management Of Glucocorticoid-induced Osteoporotic Vcfmentioning

confidence: 99%

See 1 more Smart Citation

Update on Symptomatic Treatment of Acute Vertebral Compression Fracture

Wong

Mok

2019

Journal of Clinical Rheumatology and Immunology

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“…Percutaneous vertebroplasty (PVP), as a minimally invasive, safe and effective technique, has gained wide clinical acceptance for the treatment of both primary and glucocorticosteroid-induced osteoporotic vertebral compression fractures. 6 – 9 However, PVP for adjacent vertebral stress fracture with intervertebral pseudarthrosis formation due to AS is less known. Recently, we have designed an innovative approach – percutaneous interbody fusion (PIF) – developed from PVP, which has not been reported in the literature thus far to our knowledge, especially for patients with adjacent vertebral stress fracture of AS with intervertebral pseudarthrosis formation.…”

Section: Introductionmentioning

confidence: 99%

Feasibility of percutaneous interbody fusion as a treatment for adjacent vertebral stress fracture of ankylosing spondylitis with intervertebral pseudarthrosis formation

Tian

Wang

et al. 2018

JPR

Self Cite

View full text Add to dashboard Cite

ObjectiveThe objective of this study was to evaluate the feasibility of percutaneous interbody fusion (PIF) using bone cement for adjacent vertebral stress fracture of ankylosing spondylitis (AS) with intervertebral pseudarthrosis formation.Patients and methodsFrom January 2010 to February 2018, eleven consecutive patients (seven men and four women; median age, 56.09±13.64 years; age range, 33–80 years) who underwent PIF as a treatment for adjacent stress fracture of AS with intervertebral pseudarthrosis formation were retrospectively analyzed. The Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) score were assessed before and after the procedure; meanwhile, the procedure duration, length of hospital stay and complications were assessed. Moreover, anterior/lateral and computed tomography (CT) scans were utilized for the assessment of bone cement distribution and interbody fusion.ResultsTechnical success was achieved in all patients, and they experienced good interbody fusion with bone cement after PIF. Mean VAS scores declined significantly from 8.82±0.87 before the procedure to 3.36±0.67 1 day after the procedure and 2.73±0.65 1 month after the procedure, while the mean ODI scores decreased from 82.91±3.02 before treatment to 31.64 ±2.66 1 day after treatment and 30.00±3.10 1 month after treatment. The mean procedure duration was 49.73±6.12 minutes (range, 42–65 minutes). The average length of hospital stay was 7.09±1.45 days (range, 5–10 days). Extraosseous cement leakage occurred in one case without causing any clinical complications.ConclusionPIF is a feasible therapeutic technique for adjacent vertebral stress fracture of AS with intervertebral pseudarthrosis formation, which can significantly relieve pain and stabilize the fractured spine.

show abstract

Multilevel percutaneous vertebroplasty with the Spine Jack® system in a patient with Cushing disease

Gil-Ortiz

Ramírez-Romero

Bonifacio‐Delgadillo

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

Background Percutaneous vertebroplasty (PV) is a minimally invasive procedure that requires the injection of cement into a fractured vertebral body. Spine Jack® is a vertebroplasty system with an intracorporal implant designed to restore the height of the vertebral body in osteoporotic vertebral fractures. There are no reported cases of PV with Spine Jack® system as treatment for multilevel compression fractures in patients with vertebral osteoporosis due to Cushing disease. Case presentation A 55‐year‐old man with lumbago, impaired deambulation 6 weeks prior to presentation, with Oswestry score of 72% and a visual analogue scale (VAS) score of 9 points. Imaging studies showed osteoporotic fractures at T5, T8, T11, T12, and L1‐L5 vertebrae secondary to Cushing disease. PV was performed with a Spine Jack® intracorporal implant device, in three sessions, and multiple levels were operated at each intervention. Post‐operative course demonstrated improvement of pain, height, correction of the kyphotic angle and Oswestry score, without any neurological deficits despite having nine vertebral fractures. Conclusion Percutaneous vertebroplasty with the Spine Jack® system is a safe and effective procedure to treat multilevel vertebral fractures due to Cushing disease, improving the quality of life and allowing the patient to remain pain‐free while avoiding major surgery.

show abstract

Percutaneous Vertebroplasty of the Entire Thoracic and Lumbar Vertebrae for Vertebral Compression Fractures Related to Chronic Glucocorticosteriod Use: Case Report and Review of Literature

Cited by 6 publications

References 21 publications

Update on Symptomatic Treatment of Acute Vertebral Compression Fracture

Update on Symptomatic Treatment of Acute Vertebral Compression Fracture

Feasibility of percutaneous interbody fusion as a treatment for adjacent vertebral stress fracture of ankylosing spondylitis with intervertebral pseudarthrosis formation

Multilevel percutaneous vertebroplasty with the Spine Jack® system in a patient with Cushing disease

Contact Info

Product

Resources

About